AC Immune
ACIU
18 hedge funds and large institutions have $109M invested in AC Immune in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 4 closing their positions.
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
2.62% more ownership
Funds ownership: 15.79% → 18.41% (+2.6%)
3% less capital invested
Capital invested by funds: $113M → $109M (-$3.83M)
5% less funds holding
Funds holding: 19 → 18 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DFO
Duquesne Family Office
New York
|
+$9.94M |
| 2 |
JG
Jefferies Group
New York
|
+$9.01M |
| 3 |
AG
Artal Group
Luxembourg
|
+$3.07M |
| 4 |
PC
PointState Capital
New York
|
+$2.76M |
| 5 |
Millennium Management
New York
|
+$606K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$2.43M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.67M |
| 3 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$211K |
| 4 |
Goldman Sachs
New York
|
-$136K |
| 5 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
-$73K |
ACIU Hedge Fund Activity: Q1 2017 in Review
18 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q1 2017, worth a combined $109M — down 3.4% from $113M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ACIU and 3 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 7 added.
The largest buyer was Duquesne Family Office, adding an estimated $9.94M. The largest seller was Citadel Advisors, cutting an estimated $2.43M.
- 18 institutional investors held AC Immune (ACIU) as of Q1 2017, down from 19 in Q4 2016.
- Funds reported $109M of AC Immune stock for Q1 2017, down 3.4% quarter-over-quarter.
- 3 funds opened new AC Immune positions in Q1 2017 and 4 closed out, a net change of -1 holder.
- The largest AC Immune buyer in Q1 2017 was Duquesne Family Office, an estimated $9.94M added.
- The largest AC Immune seller in Q1 2017 was Citadel Advisors, an estimated $2.43M sold.
Based on aggregated 13F filings for Q1 2017.